Literature DB >> 20553066

Cancer epidemiology and control in North-Western and Central Asia - past, present and future.

Malcolm A Moore1, Sultan Eser, Nurbek Igisinov, Saginbek Igisinov, Mohammad Ali Mohagheghi, Alireza Mousavi-Jarrahi, Gülsün Ozentürk, Mashhura Soipova, Murat Tuncer, Tomotaka Sobue.   

Abstract

The North-Western and Central region of Asia stretches from Turkey through Armenia, Georgia and Azerbaijan, to Iran and Turkmenistan, Uzbekistan, Kazakhstan, Kyrgyzstan, Tadjikistan and Afghanistan. These countries in the main share Turkic, Iranian or Caucasus ethnicity and culture and can be considered as a regional entity for cooperation in control of cancer. The present review of cancer registry and other epidemiological data was undertaken to provide an evidence base for cancer control programs and pointers to possible research collaboration. The most prevalent cancer site in males is the lung in the Western part of the region and the stomach in most of Iran and Central Asia, followed by the oesophagus in the latter two. Bladder cancer is comparatively frequent throughout. In females breast cancer is number one, generally followed by gastric, oesophageal or cervical lesions. However, there are interesting differences between countries or regions, particularly regarding the stomach. General tendencies for increase in adenocarcinomas but decrease in squamous cell carcinomas and gastric cancer point to change in environmental influence over time. Variation in risk factors depends to some extent on the level of economic development but overall the countries of the region face similar challenges in achieving effective cancer control, underlying the necessity for cooperation.

Entities:  

Mesh:

Year:  2010        PMID: 20553066

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  29 in total

1.  Clinicopathological characteristics and prognostic analysis of gastric cancer in the young adult in China.

Authors:  Miao-zhen Qiu; Zhi-qiang Wang; Dong-sheng Zhang; Hui-yan Luo; Zhi-wei Zhou; Feng-hua Wang; Yu-hong Li; Wen-qi Jiang; Rui-hua Xu
Journal:  Tumour Biol       Date:  2010-12-23

2.  Prognostic analysis in node-negative gastric cancer patients in China.

Authors:  Miao-zhen Qiu; Zhi-qiang Wang; Hui-yan Luo; Dong-sheng Zhang; Zhi-wei Zhou; Yu-hong Li; Wen-qi Jiang; Rui-hua Xu
Journal:  Tumour Biol       Date:  2010-12-22

3.  MiR-451, a potential prognostic biomarker and tumor suppressor for gastric cancer.

Authors:  Zhongxue Su; Juan Zhao; Zhonghou Rong; Wenmao Geng; Zhiyi Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

Review 4.  Current Status and Future Projections of Breast Cancer in Asia.

Authors:  Lei Fan; Paul E Goss; Kathrin Strasser-Weippl
Journal:  Breast Care (Basel)       Date:  2015-12-15       Impact factor: 2.860

5.  Barriers on Breast Cancer Early Detection Methods.

Authors:  Yasemin Erkal Aksoy; Esin Çeber Turfan; Ebru Sert; Gülengül Mermer
Journal:  J Breast Health       Date:  2015-01-01

Review 6.  State-of-the-art preoperative staging of gastric cancer by MDCT and magnetic resonance imaging.

Authors:  Joon-Il Choi; Ijin Joo; Jeong Min Lee
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

7.  Negative predictive value of preoperative computed tomography in determining pathologic local invasion, nodal disease, and abdominal metastases in gastric cancer.

Authors:  D J Kagedan; F Frankul; A El-Sedfy; C McGregor; M Elmi; B Zagorski; M E Dixon; A L Mahar; J Vasilevska-Ristovska; L Helyer; C Rowsell; C J Swallow; C H Law; N G Coburn
Journal:  Curr Oncol       Date:  2016-08-12       Impact factor: 3.677

8.  Nutrition support can bring survival benefit to high nutrition risk gastric cancer patients who received chemotherapy.

Authors:  Miaozhen Qiu; Yi-xin Zhou; Yin Jin; Zi-xian Wang; Xiao-li Wei; Hong-yu Han; Wen-feng Ye; Zhi-wei Zhou; Dong-sheng Zhang; Feng-hua Wang; Yu-hong Li; Da-jun Yang; Rui-hua Xu
Journal:  Support Care Cancer       Date:  2014-12-11       Impact factor: 3.603

9.  Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors.

Authors:  Lin Zhang; Miaozhen Qiu; Ying Jin; Jiao Ji; Baoxia Li; Xueping Wang; Shumei Yan; Ruihua Xu; Dajun Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

10.  Efficacy and safety of capecitabine as maintenance treatment after first-line chemotherapy using oxaliplatin and capecitabine in advanced gastric adenocarcinoma patients: a prospective observation.

Authors:  Miao-zhen Qiu; Xiao-li Wei; Dong-sheng Zhang; Ying Jin; Yi-xin Zhou; De-shen Wang; Chao Ren; Long Bai; Hui-yan Luo; Zhi-qiang Wang; Feng-hua Wang; Yu-hong Li; Da-jun Yang; Rui-hua Xu
Journal:  Tumour Biol       Date:  2014-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.